140 related articles for article (PubMed ID: 25971923)
1. Identification of novel drugs to target dormant micrometastases.
Hurst RE; Hauser PJ; You Y; Bailey-Downs LC; Bastian A; Matthews SM; Thorpe J; Earle C; Bourguignon LY; Ihnat MA
BMC Cancer; 2015 May; 15():404. PubMed ID: 25971923
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.
Bailey-Downs LC; Thorpe JE; Disch BC; Bastian A; Hauser PJ; Farasyn T; Berry WL; Hurst RE; Ihnat MA
PLoS One; 2014; 9(5):e98624. PubMed ID: 24878664
[TBL] [Abstract][Full Text] [Related]
3. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
4. Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy".
Hurst RE; Hauser PJ; Kyker KD; Heinlen JE; Hodde JP; Hiles MC; Kosanke SD; Dozmorov M; Ihnat MA
PLoS One; 2013; 8(5):e64181. PubMed ID: 23717563
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.
Peiris PM; Toy R; Abramowski A; Vicente P; Tucci S; Bauer L; Mayer A; Tam M; Doolittle E; Pansky J; Tran E; Lin D; Schiemann WP; Ghaghada KB; Griswold MA; Karathanasis E
J Control Release; 2014 Jan; 173():51-8. PubMed ID: 24188960
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells.
Dozmorov MG; Kyker KD; Saban R; Knowlton N; Dozmorov I; Centola MB; Hurst RE
BMC Cancer; 2006 Jan; 6():12. PubMed ID: 16412233
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
9. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
10. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
11. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
12. Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells.
Díaz-Carballo D; Acikelli AH; Bardenheuer W; Gustmann S; Malak S; Stoll R; Kedziorski T; Nazif MA; Jastrow H; Wennemuth G; Dammann P; Feigel M; Strumberg D
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):787-801. PubMed ID: 24902844
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix.
Hauser PJ; Han Z; Sindhwani P; Hurst RE
Anticancer Res; 2007; 27(2):737-40. PubMed ID: 17465196
[TBL] [Abstract][Full Text] [Related]
15. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
[TBL] [Abstract][Full Text] [Related]
17. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
18. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
Jin Y; Zou X; Feng X
Anticancer Drugs; 2010 Oct; 21(9):814-22. PubMed ID: 20724916
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of edotecarin in breast carcinoma models.
Ciomei M; Croci V; Stellari F; Amboldi N; Giavarini R; Pesenti E
Cancer Chemother Pharmacol; 2007 Jul; 60(2):229-35. PubMed ID: 17089166
[TBL] [Abstract][Full Text] [Related]
20. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
